Paul Anderson Purchases 57,471 Shares of Healius (ASX:HLS) Stock

Healius Limited (ASX:HLS) insider Paul Anderson purchased 57,471 shares of the stock in a transaction dated Friday, October 31st. The shares were purchased at an average price of A$0.89 per share, for a total transaction of A$50,976.78.

Healius Price Performance

The company has a quick ratio of 0.47, a current ratio of 0.50 and a debt-to-equity ratio of 153.54. The firm has a market capitalization of $1.01 billion, a PE ratio of -2.54, a price-to-earnings-growth ratio of -0.94 and a beta of 0.73.

Healius Company Profile

Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through three segments: Pathology, Imaging, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. It also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin cancer removal, IVF egg collection, and gynaecological surgery services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetpath Laboratory, Vetnostics, QML Vetnostics, TML Vetnostics, ASAP Laboratory, Abbott Pathology, TML Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs; Lumus Imaging; and Montserrat brands.